Business
Pfizer Bows to Trump in ‘Historic’ Drug Price-Cutting Deal
Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.
In a landmark announcement, President Trump revealed a deal with Pfizer that slashes drug prices for Americans on Medicaid on a massive scale.
Under this agreement, Pfizer will offer its medications to Medicaid at “most favored nation’s prices.”
Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.
“It’s going to have a huge impact on bringing Medicaid costs down like nothing else,” the president said.
“I can’t tell you how big this is,” he added.
The conference opened with Trump telling Pfizer CEO to his face that he is “surprised” he is agreeing to massive price cuts to his company’s drugs.
Albert Bourla smiled and stood silently as Trump announced devastating news for his company’s profits in America.
RFK Jr. heaped praise on President Trump for several minutes after he struck a deal that other politicians said was impossible.
Kennedy called it something “Democrats have wanted for 20 years, Republicans have wanted for 20 years,” but said no president had ever been able to make it happen until Trump pushed drug companies to the table.
“All we could see was all the reasons this couldn’t happen. Everybody tried. Nobody could make it happen. And it was President Trump alone who, with his doggedness and persistence, saw this clearly in a way that none of us [did],” Kennedy said.
“I can’t think of any other president in the United States that could have done this in our history.”
Dr. Oz couldn’t hide how proud he is to work for the White House — calling it a “cool place to work” after Trump did the impossible in a “historic” deal that forced pharmaceutical giants to stop ripping Americans off on drug prices.
He said the team had been working “24/7 nonstop with industry, with Albert [Bourla], with his great team at Pfizer” to get them to sell prescription drugs to Medicaid at the lowest global rate.
“We’re going to finally deliver on the fair drug prices that President Trump has been speaking about for two terms. We’re going to celebrate this historic day. I predict this historic day [will have a positive impact] in the medical field for generations to come,” Dr. Oz declared.
When Pfizer CEO Albert Bourla got his chance to speak, he revealed that President Trump made four specific requests to lower drug prices in America — and Pfizer’s deal today meets ALL of them.
Bourla admitted America was in an “unfair situation” while “other rich nations refused to pay their fair share for the medical innovation.”
That’s changing. Under the new agreement, Medicaid sale prices will drop significantly. Meanwhile, other countries that have long paid rock-bottom prices will see modest increases.
The big winner in this deal, Bourla said, was “the American patient.”
“Who else is a winner here?” he asked. “It is American innovation and American economy.”
Trump suggested that the breakthrough on drug prices could also translate to lowering health insurance.
In terms of real-world results, Trump called it “massive.” He explained how a drug that sells for $137 in America will drop to just $15 to $18.
In other countries, the same drug is sold for only $10, and they will now have to raise the price slightly.
But America is no longer footing the bill, so the rest of the world can get cheap drugs. And finally — in a move once thought impossible — Americans on Medicaid will be paying a fair price.
Business
Large-scale energy investments remain a pipe dream
I view the recent announcements by the Government of Canada as window dressing, and not addressing the fundamental issue which is that projects are drowning in bureaucratic red tape and regulatory overburden. We don’t need them picking winners and losers, a fool’s errand in my opinion, but rather make it easier to do business within Canada and stop the hemorrhaging of Foreign Direct Investment from this country.
Thanks for reading William’s Substack!
Subscribe for free to receive new posts and support my work.
Changes are afoot—reportedly, carve-outs and tweaks to federal regulations that would help attract investment in a new oil pipeline from Alberta. But any private proponent to come out of this deal will presumably be handpicked to advance through the narrow Bill C-5 window, aided by one-off fixes and exemptions.
That approach can only move us so far. It doesn’t address the underlying problem.
Anyone in the investment world will tell you a patchwork of adjustments is nowhere near enough to unlock the large-scale energy investment this country needs. And from that investor’s perspective, the horizon stretches far beyond a single political cycle. Even if this government promises clarity today in the much-anticipated memorandum of understanding (MOU), who knows whether it will be around by the time any major proposal actually moves forward.
With all of the talk of “nation-building” projects, I have often been asked what my thoughts are about what we must see from the federal government.
The energy sector is the file the feds have to get right. It is by far the largest component of Canadian exports, with oil accounting for $147 billion in 2024 (20 percent of all exports), and energy as a whole accounting for $227 billion of exports (30 percent of all exports).
Furthermore, we are home to some of the largest resource reserves in the world, including oil (third-largest in proven reserves) and natural gas (ninth-largest). Canada needs to wholeheartedly embrace that. Natural resource exceptionalism is exactly what Canada is, and we should be proud of it.
One of the most important factors that drives investment is commodity prices. But that is set by market forces.
Beyond that, I have always said that the two most important things one considers before looking at a project are the rule of law and regulatory certainty.
The Liberal government has been obtuse when it comes to whether it will continue the West Coast tanker ban (Bill C-48) or lift it to make way for a pipeline. But nobody will propose a pipeline without the regulatory and legal certainty that they will not be seriously hindered should they propose to build one.
Meanwhile, the proposed emissions cap is something that sets an incredibly negative tone, a sentiment that is the most influential factor in ensuring funds flow. Finally, the Impact Assessment Act, often referred to as the “no more pipelines bill” (Bill C-69), has started to blur the lines between provincial and federal authority.
All three are supposedly on the table for tweaks or carve-outs. But that may not be enough.
It is interesting that Norway—a country that built its wealth on oil and natural gas—has adopted the mantra that as long as oil is a part of the global economy, it will be the last producer standing. It does so while marrying conventional energy with lower-carbon standards. We should be more like Norway.
Rather than constantly speaking down to the sector, the Canadian government should embrace the wealth that this represents and adopt a similar narrative.
The sector isn’t looking for handouts. Rather, it is looking for certainty, and a government proud of the work that they do and is willing to say so to Canada and the rest of the world. Foreign direct investment outflows have been a huge issue for Canada, and one of the bigger drags on our economy.
Almost all of the major project announcements Prime Minister Mark Carney has made to date have been about existing projects, often decades in the making, which are not really “additive” to the economy and are reflective of the regulatory overburden that industry faces en masse.
I have always said governments are about setting the rules of the game, while it is up to businesses to decide whether they wish to participate or to pick up the ball and look elsewhere.
Capital is mobile and will pursue the best risk-adjusted returns it can find. But the flow of capital from our country proves that Canada is viewed as just too risky for investors.
The government’s job is not to try to pick winners and losers. History has shown that governments are horrible at that. Rather, it should create a risk-appropriate environment with stable and capital-attractive rules in place, and then get out of the way and see where the chips fall.
Link to The Hub article: Large-scale energy investments remain a pipe dream
Formerly the head of institutional equity research at FirstEnergy Capital Corp and ATB Capital Markets. I have been involved in the energy sector in either the sell side or corporately for over 25 years
Thanks for reading William’s Substack!
Subscribe for free to receive new posts and support my work.
Business
I Was Hired To Root Out Bias At NIH. The Nation’s Health Research Agency Is Still Sick

From the Daily Caller News Foundation
By Joe Duarte
Federal agencies like the National Institutes of Health (NIH) continue to fund invalid, ideologically driven “scientific” research that subsidizes leftist activists and harms conservatives and the American people at large. There’s currently no plan to stop.
Conversely, NIH does not fund obvious research topics that would help the American people, because of institutional leftist bias.
While serving as a senior advisor at NIH, I discovered many active grants like these:
“Examining Anti-Racist Healing in Nature to Protect Telomeres of Transitional Age BIPOC for Health Equity” — Take minority teens to parks in a bid to reduce telomere erosion (the shortening of repetitive DNA sequences as we age). $3.8 million in five years and no results published – not surprising, given their absurd premise.
“Ecological Momentary Assessment of Racial/Ethnic Microaggressions and Cannabis Use among Black Adults” – This rests on an invalid leftist ideological concept – “microaggressions.” An example of a “microaggression” is a white person denying he’s racist. They can’t be validly measured since they’re simply defined into existence by Orwellian leftist ideology, with no attempt to discover the alleged aggressor’s motives.
“Influence of Social Media, Social Networks, and Misinformation on Vaccine Acceptance Among Black and Latinx Individuals” — from an activist who said the phrase “The coronavirus is genetically engineered” was “misinformation” and also conducted a bizarre, partisan study based entirely on a Trump tweet about recovering from COVID.
I will be leaving the great Walter Reed Medical Center today at 6:30 P.M. Feeling really good! Don’t be afraid of Covid. Don’t let it dominate your life. We have developed, under the Trump Administration, some really great drugs & knowledge. I feel better than I did 20 years ago!
— Donald J. Trump (@realDonaldTrump) October 5, 2020
The study claimed that people saw COVID as less “serious” after the tweet. I apologize for the flashback to when Democrats demanded everyone feel the exact level of COVID panic and anti-optimism they felt (and share their false beliefs on the efficacy of school closures, masks, and vaccines ). NIH funded this study and gave him another $651,586 in July for his new “misinformation” study, including $200,000 from the Office of the Director.
I’m a social psychologist who has focused on the harms of ideological bias in academic research. Our sensemaking institutions have been gashed by a cult political ideology that treats its conjectures and abstractions as descriptively true, without argument or even explanation, and enforces conformity with inhumane psychologizing and ostracism. This ideology – which dominates academia and NIH – poses an unprecedented threat to our connection to reality, and thus to science, by vaporizing the distinction between descriptive reality and ideological tenets.
In March, I emailed Jay Bhattacharya, Director of NIH, and pitched him on how I could build an objective framework to eliminate ideological bias in NIH-funded research.
Jay seemed to agree with my analysis. We spoke on the phone, and I started in May as a senior advisor to Jay in the Office of the Director (NIH-OD).
I never heard from Jay again beyond a couple of cursory replies.
For four months, I read tons of grants, passed a lengthy federal background check, started to build the pieces, and contacted Jay about once a week with questions, follow-up, and example grants. Dead air – he was ghosting me.
Jay also bizarrely deleted the last two months’ worth of my messages to him but kept the older ones. I’d sent him a two-page framework summary, asked if I should keep working on it, and also asked if I’d done something wrong, given his persistent lack of response. No response.
In September, the contractors working at NIH-OD, me included, were laid off. No explanation was given.
I have no idea what happened here. It’s been the strangest and most unprofessional experience of my career.
The result is that NIH is still funding ideological, scientifically invalid research and will continue to ignore major topics because of leftist bias. We have a precious opportunity for lasting reform, and that opportunity will be lost without a systematic approach to eliminating ideology in science.
What’s happened so far is that DOGE cut some grants earlier this year, after a search for DEI terms. It was a good first step but caught some false positives and missed most of the ideological research, including many grants premised on “microaggressions,” “systemic racism,” “intersectionality,” and other proprietary, question-begging leftist terms. Leftist academics are already adapting by changing their terminology – this meme is popular on Bluesky:
DOGE didn’t have the right search terms, and a systematic, objective anti-bias framework is necessary to do the job. It’s also more legally resilient and persuasive to reachable insiders — there’s no way to reform a huge bureaucracy without getting buy-in from some insiders (yes, you also have to fire some people). This mission requires empowered people at every funding agency who are thoroughly familiar with leftist ideology, can cleanly define “ideology,” and build robust frameworks to remove it from scientific research.
My framework identifies four areas of bias so far:
- Ideological research
- Rigged research
- Ideological denial of science / suppression of data
- Missing research – research that would happen if not for leftist bias
The missing research at NIH likely hurts the most — e.g. American men commit suicide at unusually high rates, especially white and American Indian men, yet NIH funds no research on this. But they do fund “Hypertension Self-management in Refugees Living in San Diego.”
Similarly, NIH is AWOL on the health benefits of religious observance and prayer, a promising area of research that Muslim countries are taking the lead on. These two gaping holes suggest that NIH is indifferent to the American people and even culturally and ideologically hostile them.
Joe Duarte grew up in small copper-mining towns in Southern Arizona, earned his PhD in social psychology, and focuses on political bias in media and academic research. You can find his work here, find him on X here, and contact him at gravity at protonmail.com.
-
Energy1 day agoExpanding Canadian energy production could help lower global emissions
-
Business1 day agoWill the Port of Churchill ever cease to be a dream?
-
Great Reset2 days agoEXCLUSIVE: The Nova Scotia RCMP Veterans’ Association IS TARGETING VETERANS with Euthanasia
-
Daily Caller2 days agoSpreading Sedition? Media Defends Democrats Calling On Soldiers And Officers To Defy Chain Of Command
-
Health2 days agoDisabled Canadians petition Parliament to reverse MAiD for non-terminal conditions
-
Business1 day agoThe numbers Canada uses to set policy don’t add up
-
COVID-1914 hours agoFreedom Convoy protestor Evan Blackman convicted at retrial even after original trial judge deemed him a “peacemaker”
-
Business1 day agoNew airline compensation rules could threaten regional travel and push up ticket prices








